Yu Y - Search Results

1

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.

Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Ai Z, et al. Among authors: yu y. Cancer. 2006 Aug 15;107(4):746-56. doi: 10.1002/cncr.22044. Cancer. 2006. PMID: 16826583 Free article.

2

[Expression of glyoxalase I and its effect on cell proliferation and apoptosis in endometrial carcinoma].

Sui L, Guo QS, Zhang ZB, Jin HY, Yu YH, Feng YJ. Sui L, et al. Zhonghua Fu Chan Ke Za Zhi. 2010 Jun;45(6):429-33. Zhonghua Fu Chan Ke Za Zhi. 2010. PMID: 21029593 Chinese.

3

Snail is critical for tumor growth and metastasis of ovarian carcinoma.

Jin H, Yu Y, Zhang T, Zhou X, Zhou J, Jia L, Wu Y, Zhou BP, Feng Y. Jin H, et al. Among authors: yu y. Int J Cancer. 2010 May 1;126(9):2102-11. doi: 10.1002/ijc.24901. Int J Cancer. 2010. PMID: 19795442

4

HOXA10 is overexpressed in human ovarian clear cell adenocarcinoma and correlates with poor survival.

Li B, Jin H, Yu Y, Gu C, Zhou X, Zhao N, Feng Y. Li B, et al. Among authors: yu y. Int J Gynecol Cancer. 2009 Nov;19(8):1347-52. doi: 10.1111/IGC.0b013e3181a83f1d. Int J Gynecol Cancer. 2009. PMID: 20009888

5

FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5.

Huang Y, Jin H, Liu Y, Zhou J, Ding J, Cheng KW, Yu Y, Feng Y. Huang Y, et al. Among authors: yu y. Endocr Relat Cancer. 2010 Nov 30;18(1):13-26. doi: 10.1677/ERC-09-0308. Print 2011 Feb. Endocr Relat Cancer. 2010. PMID: 20943720

6

Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.

Gu C, Zhang Z, Yu Y, Liu Y, Zhao F, Yin L, Feng Y, Chen X. Gu C, et al. Among authors: yu y. Cancer Sci. 2011 Mar;102(3):557-64. doi: 10.1111/j.1349-7006.2010.01829.x. Epub 2011 Jan 18. Cancer Sci. 2011. PMID: 21205080 Free PMC article.

7

Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.

Zhang J, Yang Y, Zhang Z, He Y, Liu Z, Yu Y, Wu S, Cai B, Feng Y. Zhang J, et al. Among authors: yu y. Cancer Lett. 2013 Oct 10;339(2):279-87. doi: 10.1016/j.canlet.2012.10.037. Epub 2012 Nov 8. Cancer Lett. 2013. PMID: 23142288

8

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.

Zhu J, Lu X, Hua KQ, Sun H, Yu YH, Feng YJ. Zhu J, et al. Arch Gynecol Obstet. 2012 Sep;286(3):729-37. doi: 10.1007/s00404-012-2368-5. Epub 2012 May 9. Arch Gynecol Obstet. 2012. PMID: 22569715

9

Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.

Zhao S, Chen X, Lu X, Yu Y, Feng Y. Zhao S, et al. Among authors: yu y. Gynecol Oncol. 2007 Apr;105(1):45-54. doi: 10.1016/j.ygyno.2006.12.014. Epub 2007 Jan 22. Gynecol Oncol. 2007. PMID: 17240435

10

Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.

Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu X, Yu Y, Zha X, Feng Y. Huang Y, et al. Among authors: yu y. Cell Res. 2008 Jul;18(7):780-91. doi: 10.1038/cr.2008.70. Cell Res. 2008. PMID: 18574502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,339 results

Search Page

Filters